In the midst of the coronavirus pandemic normal routines seem like a distant memory for many. The same holds very true for medical imaging operations. Across the country hospital radiology departments are challenged to balance the volume of incoming patients who are ill with COVID-19 with the complexities of carefully managing infection control in a busy imaging department. Meanwhile, waitlists for non-urgent and routine imaging studies are growing out of control. 

In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive. The earliest mentions of the disease can be found in journals written a few millennia back. The fight against cancer is that old and is still ongoing. During the same period, a lot of epidemics were turned into easily treatable diseases with the assistance of evolving technologies. Tuberculosis, typhoid and malaria are some former deadly diseases that have been reduced to puppet-like structures in the hands of physicians from their previous Goliath-like presence.

After the worst of the COVID-19 pandemic has passed, hospitals are going to be overwhelmed with a large number of patients needing elective procedures. Off-site imaging companies are helping to prepare for that surge in patients by keeping imaging processes moving forward. Once hospital doors reopen, doctors will be prepared to care for their patients.